| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/15/2005 | EP1539985A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/15/2005 | EP1539973A1 Modified adenoviral vectors for use in vaccines and gene therapy |
| 06/15/2005 | EP1539971A1 Her-2/neu dna vaccine having anti-cancer activity |
| 06/15/2005 | EP1539957A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 06/15/2005 | EP1539956A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/15/2005 | EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 06/15/2005 | EP1539939A1 Method for the production of virus-analog particles for packing biologically active macromolecule by in vitro assembly of capsomers to which the macromolecules are bound |
| 06/15/2005 | EP1539938A1 Chimeric gb virus b (gbv-b) |
| 06/15/2005 | EP1539937A2 Methods for propagating adenovirus and virus produced thereby |
| 06/15/2005 | EP1539933A2 Methods of organ regeneration |
| 06/15/2005 | EP1539814A2 Full-length interferon gamma polypeptide variants |
| 06/15/2005 | EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 06/15/2005 | EP1539808A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/15/2005 | EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 06/15/2005 | EP1539802A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 06/15/2005 | EP1539799A2 Crosslinked compounds and methods of making and using thereof |
| 06/15/2005 | EP1539788A2 METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING |
| 06/15/2005 | EP1539785A2 Gene regulation in transgenic animals using a transposon-based vector |
| 06/15/2005 | EP1539689A2 Antisense modulation of endothelial lipase expression |
| 06/15/2005 | EP1539247A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 06/15/2005 | EP1539246A2 Central airway administration for systemic delivery of therapeutics |
| 06/15/2005 | EP1539245A2 Methods and materials for treating human papillomavirus infections |
| 06/15/2005 | EP1539208A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/15/2005 | EP1539198A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/15/2005 | EP1539189A2 Method of using anti-apoptotic factors in gene expression |
| 06/15/2005 | EP1539041A1 Devices delivering therapeutic agents and methods regarding the same |
| 06/15/2005 | EP1538904A2 Immunostimulatory nucleic acids |
| 06/15/2005 | EP1309625B1 Therapeutic compounds for ovarian cancer |
| 06/15/2005 | EP1212420B1 Conditional immortalisation of cells |
| 06/15/2005 | EP1162955B1 Nanoparticles, complexes with polynucleotides and their use |
| 06/15/2005 | EP1106692B1 Rna virus vector having contact infiltration capability |
| 06/15/2005 | EP1015035A4 Vaccination by topical application of genetic vectors |
| 06/15/2005 | EP0954602B1 Hereditary hemochromatosis gene |
| 06/15/2005 | CN1628179A Gene and protein relating to hepatocellular carcinoma |
| 06/15/2005 | CN1628169A Artificial human chromosome containing human antibody lambda light chain gene |
| 06/15/2005 | CN1628128A Mammal prolactin variants |
| 06/15/2005 | CN1627960A Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides |
| 06/15/2005 | CN1626652A Method for accelerating quick growth of animals and method for improving quality of meat |
| 06/15/2005 | CN1626245A New application of chromaffin cell of adrenal medulla or opium peptide energy cell |
| 06/15/2005 | CN1206361C Construction and application of serial universal adenovirus accompanying virus carriers |
| 06/15/2005 | CN1206359C High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 06/14/2005 | US6906041 Treatment of immune diseases |
| 06/14/2005 | US6905873 Recombinant p53 adenovirus methods and compositions |
| 06/14/2005 | US6905862 Method for producing recombinant adenovirus |
| 06/14/2005 | US6905844 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/14/2005 | US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905682 Hybrid nucleic acids, ant antibodies thereof; insecticide |
| 06/14/2005 | US6905681 Methods for selectively stimulating proliferation of T cells |
| 06/14/2005 | US6905680 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 06/14/2005 | US6905678 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 06/14/2005 | CA2284100C New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof |
| 06/14/2005 | CA2164088C Plasmids suitable for gene therapy |
| 06/09/2005 | WO2005052172A1 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv) |
| 06/09/2005 | WO2005052171A2 Retroviral and lentiviral vectors |
| 06/09/2005 | WO2005052166A1 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases. |
| 06/09/2005 | WO2005052164A1 Gene therapy |
| 06/09/2005 | WO2005052157A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | WO2005052143A2 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses |
| 06/09/2005 | WO2005052122A2 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN |
| 06/09/2005 | WO2005051971A1 Reduction of dermal scarring |
| 06/09/2005 | WO2005051970A2 Highly parallel dna synthesiser based on matrices |
| 06/09/2005 | WO2005051433A1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 06/09/2005 | WO2005051432A1 Therapeutic regimen for treating cancer |
| 06/09/2005 | WO2005051431A1 Colloidal delivery system for biological therapeutic agents |
| 06/09/2005 | WO2005051430A1 Novel use of adenoviruses and nucleic acids that code for said viruses |
| 06/09/2005 | WO2005051421A2 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 06/09/2005 | WO2005051413A2 Disease associated genes |
| 06/09/2005 | WO2005051351A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 06/09/2005 | WO2005030939A3 Method and composition for regulating expansion of stem cells |
| 06/09/2005 | WO2005030787A3 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 06/09/2005 | WO2005028658A3 Recombinant influenza vectors with a polii promoter and ribozymes |
| 06/09/2005 | WO2005017153A3 Methods for synthesis of defined polynucleotides |
| 06/09/2005 | WO2005014039A3 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |
| 06/09/2005 | WO2005012537A3 Adenoviral vector-based vaccines |
| 06/09/2005 | WO2005011722A3 Use of vegf-c or vegf-d in reconstructive surgery |
| 06/09/2005 | WO2005008248A3 Diagnosis and treatment of cervical cancer |
| 06/09/2005 | WO2005007175A3 Cadherin directed molecular and cellular localization |
| 06/09/2005 | WO2005001103A3 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 06/09/2005 | WO2004111195A3 Methods and use of zona-free therapeutic cloning |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124800 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124792 Expression vector comprising nucleotide sequences coding G-protein coupled photoreceptor proteins for use in tools in pharmaceutical design; bioreactors and heterologous protein expression |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124572 Compositions and their uses directed to signal tranducers |
| 06/09/2005 | US20050124571 Exposure a suspension of active agents such as viral vector and microparticles to condition which results in greater efficiency; injecting mixture, then removal of microparticles |
| 06/09/2005 | US20050124570 Using carnitine for producing genetic engineered proteins |
| 06/09/2005 | US20050124565 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 06/09/2005 | US20050124564 Administering vector comprising nucleic acid sequence encoding erythropoietin; controlling gene expression |
| 06/09/2005 | US20050124068 Hepatocellular carcinoma specific promoter and uses thereof |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124007 Human mesencephalon cell lines and methods of use therefor |
| 06/09/2005 | US20050123998 Nucleotide sequences coding gprotein coupled receptor for use in identifying modulator for prevention and treatment of asthma, inflammatory, heart land cardiovascular disorders |
| 06/09/2005 | US20050123978 Knockout mouse for the tumor suppressor gene ANX7 |
| 06/09/2005 | US20050123969 Using homeobox and death-associated protein kinase (DAP-kinase) gene expression as diagnostic indicators of cell proliferative disorders of respiratory system |
| 06/09/2005 | US20050123942 Nucleotide sequences coding kinase for use as tool in diagnosis, prevention and treatment of restenosis, cell proliferative and ischemic disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123909 Compositions and methods for treating cells having double minute dna |
| 06/09/2005 | US20050123904 Using viral kinase as tool to identify modulators of gammaherpesviral replication; enzyme inhibitors and gene expression inhibition; viricides |